MENU

DMAC DiaMedica Therapeutics Forecast, Technical & Fundamental Analysis

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published Earnings

DMAC is expected to report earnings to rise 5.26% to -20 cents per share on November 12

DiaMedica Therapeutics DMAC Stock Earnings Reports
Q3'26
Est.
$-0.20
Q2'26
Est.
$-0.19
Q1'26
Est.
$-0.19
Q4'25
Est.
$-0.17
Q3'25
Est.
$-0.17
The last earnings report on August 10 showed earnings per share of -18 cents, meeting the estimate of -18 cents. With 54.63K shares outstanding, the current market capitalization sits at 504.74M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MCHX1.400.07
+5.26%
Marchex
WMK82.452.56
+3.20%
Weis Markets
MEVO10.03-0.02
-0.20%
M Evo Global Acquisition Corp II
PCVX66.36-1.17
-1.73%
Vaxcyte
SHFS0.02-0.01
-35.89%
SHF Holdings Inc.

DMAC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DMAC has been loosely correlated with ANNX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if DMAC jumps, then ANNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DMAC
1D Price
Change %
DMAC100%
+0.21%
ANNX - DMAC
47%
Loosely correlated
-0.47%
EDIT - DMAC
47%
Loosely correlated
-8.91%
TSHA - DMAC
45%
Loosely correlated
-2.17%
VIR - DMAC
44%
Loosely correlated
-3.63%
SLDB - DMAC
44%
Loosely correlated
+2.14%
More
A.I. Advisor
published General Information

General Information

a developer of novel therapeutic compounds for diabetes and other diseases

Industry Biotechnology

Industry
Biotechnology
Address
301 Carlson Parkway
Phone
+1 763 496-5454
Employees
35
Web
https://www.diamedica.com
DiaMedica Therapeutics (DMAC) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com